ABCL - AbCellera Bio Market Capitalization
The founder maintains control over the biotech system through special shares, while the clearly visualized share price dynamics, reaching 3.79, confirm a prolonged period of profit extraction with high transaction transparency. AbCellera Biologics (ABCL) relies on the application of artificial intelligence for ultra-fast antibody discovery, positioning the company as a valuable R&D partner. The environmental profile is based on the safe disposal of reagents and energy efficiency within laboratories.
Comprehensive metric breakdowns and analytics for AbCellera Biologics Inc (ABCL)
- current price and projected stock value:
- market capitalization statistics:
- issuer book value statistics:
- debt level and financial liquidity data:
Total Debt to Capital AbCellera Biologics|ABCL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital AbCellera Corp|ABCL - Company Aggregate Debts|Debt to Book Capitalization Ratio AbCellera Bio|ABCL - Company Long-Term Loans and Borrowings|Company Short-Term Debt AbCellera|Quick Ratio abcellera.com
- business earnings and investment ratios data:
ABCL - Net Profit|Future Profit AbCellera Biologics|ABCL - Company Value to Net Income|Forward P/E Multiple abcellera.com|ABCL - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AbCellera Bio|ABCL - Operating profit before deduction of amortization|Earnings per share for the last twelve months AbCellera|ABCL - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months abcellera.com|ABCL - Earnings growth in current year|Net earnings per share growth forecast for next year AbCellera Biologics
Fundamental company analysis:ABCL (AbCellera Biologics)
Market capitalization represents the aggregate value of all the issuer's shares, reflecting the current market valuation of the business and investor confidence in its future cash flows. When analyzing the issuer's capitalization metric, it is important to note that for AbCellera Biologics (ABCL), value is driven by the success of clinical trials and royalties, which renders the chart's dynamics independent of macroeconomic cycles or inflationary processes.
Key competitors
Market Capitalization ARGX (argenx)|BioNTech Inc. - Market Value|Abivax S.A. - Market Capitalization|ADMA Corp (ADMA) - Market Valuation|Protagonist Therapeutics (PTGX) - Market Value|IMVT (immunovant.com) - Market Value|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation Tourmaline|PGEN (Precigen, Inc.) - Market Capitalization|Market Capitalization pharming.com|Market Valuation NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Market Value|Market Capitalization ZBIO (Zenas Biopharma, Inc.)|Market Capitalization Immunome Bio (IMNM)|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|Aerovate - Market Capitalization|ACRS - Market Capitalization|KYTX: Market Capitalization|TLSA (tizianalifesciences.com) - Market Value|CABA (Cabaletta Bio) - Market Capitalization|Market Valuation Ventyx Biosciences Inc. (VTYX)|Market Capitalization THTX|AVTX - Market Value|Market Value Eledon Pharmaceuticals ELDN|agenusbio.com - Market Value|CLYM - Market Value|ZURA: Market Value|ATYR: Market Capitalization|Market Value Adagene Inc. (ADAG)|Market Value ImageneBio|STTK: Market Value|Market Capitalization EQ|Market Capitalization connectbiopharm.com (CNTB)|Immunic - Market Valuation|Market Value ATRA|InflaRx GmbH - Market Capitalization|XFOR: Market Value|ACET: Market Capitalization|CELU - Market Capitalization|Market Value INmune Bio Corp|Market Value Barinthus Biotherapeutics Corp BRNS|Market Value Kezar Life Sciences (KZR)|Market Value SABS (sabbiotherapeutics.com)|Market Value Akari Therapeutics Plc AKTX|Enlivex Therapeutics Ltd (ENLV) - Market Value|Q32 Bio Corp - Market Capitalization|Market Capitalization GeoVax Corp (GOVX)|EDSA: Market Capitalization|IBIO - Market Capitalization|CARM (Carisma Therapeutics Inc) - Market Capitalization|Market Valuation XTL Biopharmaceuticals Ltd (XTLB)|Market Value Bolt Biotherapeutics (BOLT)|Market Capitalization hcwbiologics.com|Market Capitalization APVO (Aptevo Therapeutics Inc.)|Market Capitalization aimimmuno.com AIM|Aditxt Corp - Market Capitalization|GRI: Market Value|XRTX: Market Capitalization|Market Valuation Vyome Therapeutics|Market Value Revelation Biosciences|Market Value INDP|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|CALI: Market Valuation|Market Capitalization AFMD (Affimed N.V.)|Market Value ALLK|HOOKIPA - Market Capitalization|IGMS - Market Capitalization|iTeos Therapeutics, Inc. (ITOS) - Market Value|Ocean Biomedical Inc - Market Value|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
